Tag: MFDS
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from MFDS
Healthcare News
0
0
0
20 Sep, 08:04 AM
